We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Ore.) have updated their bipartisan drug pricing legislation with provisions to reduce out-of-pocket expenses — and President Trump has said he would sign it into law. Read More
Four high-ranking House Republicans introduced drug pricing legislation Monday designed to replace House Speaker Nancy Pelosi’s H.R. 3, a bill they dismissed as one-sided and doomed to fail. Read More
The FDA hit Enzyvant with a complete response letter for its regenerative tissue therapy RVT-802, an investigational drug for a rare immunodeficiency disorder. Read More
Healthcare regulators have set their sights on type 2 diabetes drug metformin to see if it contains unsafe amounts of N-nitrosodimethylamine (NDMA). Read More